Skip to Main Content

Paper Details

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy.
Ann Oncol
27
2023
GBM, Glioma, MCP, PD, PD-1, PSVRIPO, TME, TME tumours, anti-PD-1, cytotoxic T, cytotoxic T-lymphocyte, endothelial cell gene expression, glioblastoma, glioblastoma tumour, immune populations, intracranial malignancies, lymphocyte, mesenchymal+, microenvironment cell population, patient, patients, programmed cell death protein 1, subtypes, tumour, tumours
Author NameAffiliation
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Ahmed IdbaihSorbonne Universite, Inserm, CNRS, Paris Brain Institute (ICM), Hopitaux Universitaires La Pitie Salpetriere-Charles Foix
Johan M KrosErasmus Medical Center
  • 1 - 3

Datasets

Dataset
Description
Source Link
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Release 1.2